Some of the greatest challenges of our times continue to be in providing adequate health care and sufficient nutrition to an ever-growing population.
Preventive treatment of infections in the form of vaccines rather than therapeutic intervention is a priority in the development efforts in both the human and animal health sectors.
Development times as well as development cost of new and efficient vaccines are considerable and a very large number of "research leads" are screened and studied each year by the Human and Animal Health industries as well as independent research organizations.
The time and expense involved in testing the viability of each compound, as well as the scale-up to produce sufficient test quantities is quite considerable using the conventional fermentation methodology.
More than 90% of the genes cloned in bacoluvirus expression system are efficiently expressed in larvae and due to the efficiency and speed of Algenex’s expression and production technology we are able to generate a proof of concept of a specific protein expression in less than a month.
|
